Norwegian Medicines Agency head Gro Ramsten Wesenberg talks to Faraz Kermani about clearing backlogs, implementing EU regulations, counterfeiting and other regulatory developments.
The Norwegian Medicines Agency (NOMA) is making strides in its bid to bolster its regulation of drugs and to align Norway’s medicinal product rules with those of the European Union...
Please login to read the full article.
